211
Views
19
CrossRef citations to date
0
Altmetric
Research Article

High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers

, , , , , , , , , & show all
Pages 586-593 | Received 24 Oct 2011, Accepted 12 Jan 2012, Published online: 05 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Paul Harrison. (2012) Advances in the monitoring of anti-P2Y12 therapy. Platelets 23:7, pages 510-525.
Read now

Articles from other publishers (17)

Yao Yao, Xiaoye Li, Zi Wang, Shikun Xu & Qianzhou Lv. (2023) The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study. International Journal of Clinical Pharmacy 45:2, pages 461-472.
Crossref
M. Berteotti, A. M. Gori, B. Giusti, A. Fortini, G. Grossi, N. Ciardetti, A. Migliorini, E. Lotti, R. Valenti, C. Di Mario, N. Marchionni & R. Marcucci. (2023) Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy. Journal of Thrombosis and Thrombolysis 55:4, pages 667-679.
Crossref
Masahiro Tsuji, Yusuke Kawai, Toru Miyoshi, Eisuke Saito, Kohei Kawamura, Tamaki Ono, Koji Tokioka, Tohru Ohe, Kazufumi Nakamura & Hiroshi Ito. (2022) High platelet reactivity is a predictor of left ventricular remodelling in patients with acute myocardial infarction. ESC Heart Failure.
Crossref
Mohitosh Biswas, Chonlaphat Sukasem, Most Sumaiya Khatun Kali & Baharudin Ibrahim. (2022) Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis . Pharmacogenomics 23:3, pages 207-220.
Crossref
Matej Samoš, Ingrid Škorňová, Tomáš Bolek, Lucia Stančiaková, Barbora Korpallová, Peter Galajda, Ján Staško, Peter Kubisz & Marián Mokáň. (2021) Viscoelastic Hemostatic Assays and Platelet Function Testing in Patients with Atherosclerotic Vascular Diseases. Diagnostics 11:1, pages 143.
Crossref
Gregory F. Guzauskas, Anirban Basu, Josh J. Carlson & David L. Veenstra. (2019) Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy. Value in Health 22:9, pages 988-994.
Crossref
Phillip A. Bonney, Benjamin Yim, Waleed Brinjikji & Brian P. Walcott. (2019) Pharmacogenomic considerations for antiplatelet agents: the era of precision medicine in stroke prevention and neurointerventional practice. Molecular Case Studies 5:2, pages a003731.
Crossref
Anna Maria Gori, Elisa Grifoni, Renato Valenti, Betti Giusti, Rita Paniccia, Guido Parodi, Angela Migliorini, David Antoniucci, Rosanna Abbate, Gian Franco Gensini & Rossella Marcucci. (2016) High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI. European Journal of Internal Medicine 30, pages 49-54.
Crossref
T Raymond Foley, Stephen W Waldo & Ehrin J Armstrong. (2016) Antithrombotic therapy in peripheral artery disease. Vascular Medicine 21:2, pages 156-169.
Crossref
Rossella Marcucci, Elisa Grifoni & Betti Giusti. (2016) On-treatment platelet reactivity: State of the art and perspectives. Vascular Pharmacology 77, pages 8-18.
Crossref
Rossella Marcucci. (2015) Resistance to antiplatelet drugs. Can it be assessed?. IJC Metabolic & Endocrine 8, pages 31-33.
Crossref
Michael J. SorichAndrew RowlandRoss A. McKinnonMichael D. Wiese. (2014) CYP2C19 Genotype Has a Greater Effect on Adverse Cardiovascular Outcomes Following Percutaneous Coronary Intervention and in Asian Populations Treated With Clopidogrel . Circulation: Cardiovascular Genetics 7:6, pages 895-902.
Crossref
Alfi Yasmina, Anthonius de Boer, Olaf H Klungel & Vera HM Deneer. (2014) Pharmacogenomics of oral antiplatelet drugs. Pharmacogenomics 15:4, pages 509-528.
Crossref
Rossella Marcucci, Gabriele Cioni, Betti Giusti, Cinzia Fatini, Lorenza Rossi, Maddalena Pazzi & Rosanna Abbate. (2014) Gender and Anti-thrombotic Therapy: from Biology to Clinical Implications. Journal of Cardiovascular Translational Research 7:1, pages 72-81.
Crossref
Fabrizio D’Ascenzo, Umberto Barbero, Marta Bisi, Claudio Moretti, Pierluigi Omedè, Enrico Cerrato, Giorgio Quadri, Federico Conrotto, Giuseppe Biondi Zoccai, James J. DiNicolantonio, Mauro Gasparini, Sripal Bangalore & Fiorenzo Gaita. (2014) The Prognostic Impact of High On-Treatment Platelet Reactivity with Aspirin or ADP Receptor Antagonists: Systematic Review and Meta-Analysis. BioMed Research International 2014, pages 1-13.
Crossref
Betti Giusti, Claudia Saracini, Silvia Galora & Rossella Marcucci. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine 509 541 .
Rossella Marcucci, Betti Giusti & Rosanna Abbate. (2013) Personalized antiplatelet therapy in acute coronary syndromes: a dead-end street or a future scenario?. Interventional Cardiology 5:6, pages 601-604.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.